1 x Application (50.29%) | 63.06ms |
1 x Booting (49.69%) | 62.30ms |
Backtrace |
|
select * from `payment_gateways` where `name` = 'Stripe' limit 1
Bindings |
|
Backtrace |
|
select * from `payment_gateways` where `name` = 'Stripe' limit 1
Bindings |
|
Backtrace |
|
select * from `products` where `slug` = 'nr-293-week-2-discussion-safety-precautions-with-chemotherapeutics' and `products`.`deleted_at` is null limit 1
Bindings |
|
Backtrace |
|
select * from `payment_gateways` where `is_for_subscription` = 0 and `status` = 1
Bindings |
|
Backtrace |
|
select * from `pages` where `status` = 1
Bindings |
|
Backtrace |
|
select * from `site_setting` limit 1
Backtrace |
|
select * from `plans`
Backtrace |
|
select * from `product_categories` where `product_categories`.`product_id` = 3152 and `product_categories`.`product_id` is not null
Bindings |
|
Backtrace |
|
select * from `subscription_plan_user` where `user_id` is null and `category_id` in (68) limit 1
Bindings |
|
Backtrace |
|
select * from `subscription_plan` where `id` is null limit 1
Backtrace |
|
select * from `pages` where `status` = 1
Bindings |
|
Backtrace |
|
select * from `site_setting` limit 1
Backtrace |
|
select * from `pages` where `status` = 1
Bindings |
|
Backtrace |
|
select * from `site_setting` limit 1
Backtrace |
|
select * from `pages` where `status` = 1
Bindings |
|
Backtrace |
|
select * from `site_setting` limit 1
Backtrace |
|
200
[]
[]
0 of 0array:17 [▼ "accept" => array:1 [▶ 0 => "text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.7" ] "accept-encoding" => array:1 [▶ 0 => "gzip, deflate, br, zstd" ] "content-length" => array:1 [▶ 0 => "0" ] "host" => array:1 [▶ 0 => "securegrades.com" ] "pragma" => array:1 [▶ 0 => "no-cache" ] "user-agent" => array:1 [▶ 0 => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)" ] "cache-control" => array:1 [▶ 0 => "no-cache" ] "sec-ch-ua" => array:1 [▶ 0 => ""HeadlessChrome";v="129", "Not=A?Brand";v="8", "Chromium";v="129"" ] "sec-ch-ua-mobile" => array:1 [▶ 0 => "?0" ] "sec-ch-ua-platform" => array:1 [▶ 0 => ""Windows"" ] "upgrade-insecure-requests" => array:1 [▶ 0 => "1" ] "sec-fetch-site" => array:1 [▶ 0 => "none" ] "sec-fetch-mode" => array:1 [▶ 0 => "navigate" ] "sec-fetch-user" => array:1 [▶ 0 => "?1" ] "sec-fetch-dest" => array:1 [▶ 0 => "document" ] "priority" => array:1 [▶ 0 => "u=0, i" ] "x-https" => array:1 [▶ 0 => "1" ] ]
[]
0 of 0array:5 [▼ "content-type" => array:1 [▶ 0 => "text/html; charset=UTF-8" ] "cache-control" => array:1 [▶ 0 => "no-cache, private" ] "date" => array:1 [▶ 0 => "Mon, 14 Apr 2025 09:13:14 GMT" ] "set-cookie" => array:2 [▶ 0 => "XSRF-TOKEN=eyJpdiI6IkhLZ1ZMNVJZRTdIMm13TkNCSTNSUUE9PSIsInZhbHVlIjoiVTNzMldtb1ZvTnJ4cHdMano0ck5VMTZnMkE5YUNaWFFLQ1VreGZCakxhbTNIS0R3SGZaUXdiN1BsN0ZIU0hLMWp1bHZwSlNObjlHVkxnaTJ4aVhrVUs1b3owYnZRa25sMDI4aVBZMUFzQkx4VlUrVDQrR1hVVE5XWDNJT0tKMEEiLCJtYWMiOiJiNDc0NTlkNzZmN2U1OGE1OTZlYmI4MWQ3ZGUzMDQwOTJiNmFkZjIyYTQwODhhNzI0ZjJlZWUzODk2ZjQzNzVhIiwidGFnIjoiIn0%3D; expires=Mon, 14 Apr 2025 11:13:14 GMT; Max-Age=7200; path=/; secure; samesite=lax ◀XSRF-TOKEN=eyJpdiI6IkhLZ1ZMNVJZRTdIMm13TkNCSTNSUUE9PSIsInZhbHVlIjoiVTNzMldtb1ZvTnJ4cHdMano0ck5VMTZnMkE5YUNaWFFLQ1VreGZCakxhbTNIS0R3SGZaUXdiN1BsN0ZIU0hLMWp1bHZwS ▶" 1 => "securegrades_session=eyJpdiI6Ijc5VWlrMk5GQmJyZDMrM3JMc2pubUE9PSIsInZhbHVlIjoiM21CVElmZFFRN1Z2ZzNXeVhJMU1BRmxxY1dXK1NXbHdVSDlXVlgvL1NaTWQ2OGttb0JNMHh1U2ZTcUNvVG52RWtTZkorM2tYNzdaUGlwOG9jMUtXQVYwWmpKMk5KU1ExMDNGdnhSb0NxUFJPSnFvSDhuakdWTW1vUkhSM0w5WloiLCJtYWMiOiJiMmY4NWFkYTg4ZGUxMmU4NGIxZDFlNWJlZDU0MDg0YzJkYTVjN2Q0M2Q2ZTNkZWI2MWJiMDM4ODBhOWJhNmIzIiwidGFnIjoiIn0%3D; expires=Mon, 14 Apr 2025 11:13:14 GMT; Max-Age=7200; path=/; httponly; samesite=lax ◀securegrades_session=eyJpdiI6Ijc5VWlrMk5GQmJyZDMrM3JMc2pubUE9PSIsInZhbHVlIjoiM21CVElmZFFRN1Z2ZzNXeVhJMU1BRmxxY1dXK1NXbHdVSDlXVlgvL1NaTWQ2OGttb0JNMHh1U2ZTcUNvVG5 ▶" ] "Set-Cookie" => array:2 [▶ 0 => "XSRF-TOKEN=eyJpdiI6IkhLZ1ZMNVJZRTdIMm13TkNCSTNSUUE9PSIsInZhbHVlIjoiVTNzMldtb1ZvTnJ4cHdMano0ck5VMTZnMkE5YUNaWFFLQ1VreGZCakxhbTNIS0R3SGZaUXdiN1BsN0ZIU0hLMWp1bHZwSlNObjlHVkxnaTJ4aVhrVUs1b3owYnZRa25sMDI4aVBZMUFzQkx4VlUrVDQrR1hVVE5XWDNJT0tKMEEiLCJtYWMiOiJiNDc0NTlkNzZmN2U1OGE1OTZlYmI4MWQ3ZGUzMDQwOTJiNmFkZjIyYTQwODhhNzI0ZjJlZWUzODk2ZjQzNzVhIiwidGFnIjoiIn0%3D; expires=Mon, 14-Apr-2025 11:13:14 GMT; path=/; secure ◀XSRF-TOKEN=eyJpdiI6IkhLZ1ZMNVJZRTdIMm13TkNCSTNSUUE9PSIsInZhbHVlIjoiVTNzMldtb1ZvTnJ4cHdMano0ck5VMTZnMkE5YUNaWFFLQ1VreGZCakxhbTNIS0R3SGZaUXdiN1BsN0ZIU0hLMWp1bHZwS ▶" 1 => "securegrades_session=eyJpdiI6Ijc5VWlrMk5GQmJyZDMrM3JMc2pubUE9PSIsInZhbHVlIjoiM21CVElmZFFRN1Z2ZzNXeVhJMU1BRmxxY1dXK1NXbHdVSDlXVlgvL1NaTWQ2OGttb0JNMHh1U2ZTcUNvVG52RWtTZkorM2tYNzdaUGlwOG9jMUtXQVYwWmpKMk5KU1ExMDNGdnhSb0NxUFJPSnFvSDhuakdWTW1vUkhSM0w5WloiLCJtYWMiOiJiMmY4NWFkYTg4ZGUxMmU4NGIxZDFlNWJlZDU0MDg0YzJkYTVjN2Q0M2Q2ZTNkZWI2MWJiMDM4ODBhOWJhNmIzIiwidGFnIjoiIn0%3D; expires=Mon, 14-Apr-2025 11:13:14 GMT; path=/; httponly ◀securegrades_session=eyJpdiI6Ijc5VWlrMk5GQmJyZDMrM3JMc2pubUE9PSIsInZhbHVlIjoiM21CVElmZFFRN1Z2ZzNXeVhJMU1BRmxxY1dXK1NXbHdVSDlXVlgvL1NaTWQ2OGttb0JNMHh1U2ZTcUNvVG5 ▶" ] ]
0 of 0array:4 [▼ "_token" => "Tvvi3oTvMyFN9oHdSJZauDwqY9L3V6zJmdrIurBy" "_previous" => array:1 [▶ "url" => "https://securegrades.com/checkout/nr-293-week-2-discussion-safety-precautions-with-chemotherapeutics" ] "_flash" => array:2 [▶ "old" => [] "new" => [] ] "PHPDEBUGBAR_STACK_DATA" => [] ]